Phase II Study of Gemcitabine Combined with Uracil-Tegafur in Metastatic Pancreatic Cancer

Publisher： Karger

E-ISSN： 1423-0232|66|1|32-37

ISSN： 0030-2414

Source： Oncology, Vol.66, Iss.1, 2004-03, pp. : 32-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study of Uracil-Tegafur in Patients with Metastatic Pancreatic Cancer

By  

Oncology, Vol. 62, Iss. 3, 2002-06 ,pp. : 223-227

Karger

Access to resources Recommend Favorite

Phase II Study of Oral Tegafur/Uracil and Leucovorin plus Bevacizumab as a First-Line Therapy for Elderly Patients with Advanced or Metastatic Colorectal Cancer

By  

Oncology, Vol. 89, Iss. 3, 2015-05 ,pp. : 152-158

Karger

Access to resources Recommend Favorite

Phase II Study of Cisplatin Combined with Weekly Gemcitabine in the Treatment of Patients with Metastatic Pancreatic Carcinoma

By  

Pancreatology, Vol. 6, Iss. 6, 2007-03 ,pp. : 635-641

Karger

Access to resources Recommend Favorite

Phase II Trial of Oxaliplatin and Tegafur/Uracil and Oral Folinic Acid for Advanced or Metastatic Colorectal Cancer in Elderly Patients

By  

Oncology, Vol. 69, Iss. 2, 2005-09 ,pp. : 122-129

Karger

Access to resources Recommend Favorite

A Phase II Study of Gemcitabine and 5-Fluorouracil in Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study (E3296)

By  

Oncology, Vol. 58, Iss. 3, 2000-04 ,pp. : 215-218

Karger

Access to resources Recommend Favorite